Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lantheus Holdings (NQ: LNTH ) 97.86 +2.95 (+3.11%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Lantheus Holdings < Previous 1 2 3 Next > Lantheus Reports Second Quarter 2024 Financial Results July 31, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time July 17, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Massive Breakout: This ETF Signals Big Gains for Small-Cap Stocks July 15, 2024 The IWM ETF broke above multi-year resistance last week, driven by lower-than-expected June inflation data, leading to a weekly gain of 6.11%. Via MarketBeat Topics ETFs Economy Exposures Interest Rates Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer’s Disease July 15, 2024 Acquisition Expands Pipeline and Strengthens Alzheimer’s Diagnostic Capabilities From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus Welcomes CMS’ Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient Access July 10, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus Appoints Jamie Spaeth as Chief People Officer July 08, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers June 27, 2024 Deal Further Strengthens Lantheus’ Prostate Cancer Portfolio and Expands Pipeline to Include Breast Cancer From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform June 03, 2024 The integrated aPROMISE solution to be demonstrated on Siemens Healthineers’ syngo.via platform at the SNMMI annual meeting From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus to Present at the William Blair 44th Annual Growth Stock Conference May 28, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Insider Trading is Good News for These Stocks May 20, 2024 Insiders are buying these hot stocks that have ample upside for investors. The list includes pharma, entertainment, and financial stocks and Berkshire buys. Via MarketBeat Lantheus Announces Executive Appointments to Accelerate Innovation May 15, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus Reports First Quarter 2024 Financial Results May 02, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time April 18, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024 March 05, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients March 04, 2024 DEFINITY is the #1 utilized ultrasound enhancing agent in the U.S. for patients with suboptimal echocardiograms From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer February 28, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results February 22, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging February 13, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time February 08, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus Announces CEO Succession Plan January 23, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA® (Lutetium Lu 177 Dotatate) January 11, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics January 09, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus Reports Preliminary Fiscal Year 2023 Revenue January 09, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer December 18, 2023 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus to Present at the Jefferies London Healthcare Conference November 08, 2023 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus Reports Third Quarter 2023 Financial Results November 02, 2023 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus to Host Third Quarter 2023 Earnings Conference Call and Webcast on November 2, 2023, at 8:00 a.m. Eastern Time October 19, 2023 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus Announces Top Rated Oral Presentation Featuring PYLARIFY AI™ at the 2023 European Association of Nuclear Medicine (EANM) Annual Meeting September 01, 2023 From Lantheus Holdings, Inc. Via GlobeNewswire Lantheus to Present at the Wells Fargo Healthcare Conference August 31, 2023 From Lantheus Holdings, Inc. Via GlobeNewswire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.